Latest News

12345678910
Intra-Cellular Therapies Stock Is Surging Monday: What's Going On?benzinga.com
Shares of Intra-Cellular Therapies Inc. (NASDAQITCI) are trading higher Monday after Johnson & Johnson agreed to acquire the company.
Via Benzinga · January 13, 2025
Why SoundHound AI Stock Skyrocketed 835.8% in 2024 but Is Plummeting in 2025fool.com
Via The Motley Fool · January 13, 2025
Broadcom's $3 Billion Bet: Balancing Market Signals, AI-Driven Growthbroadcom
Broadcom Inc. (AVGO) navigates bullish trend but faces selling pressure.
Via Benzinga · January 13, 2025
Aerospace And Defense Stocks To Watch: The Biggest U.S. Contractors By Revenuetalkmarkets.com
The aerospace and defense industry plays a pivotal role not just in national security but also the stock market.
Via Talk Markets · January 13, 2025
United Airlines Earnings Preview: Could Airline Impress Investors After Delta's Strong Guidance?benzinga.com
A United Airlines analyst sees clear skies ahead for company after Delta's recent earnings per share and revenue beat.
Via Benzinga · January 13, 2025
Why FuboTV Stock Was Falling Todayfool.com
Via The Motley Fool · January 13, 2025
Unpacking the Latest Options Trading Trends in Amgenbenzinga.com
Via Benzinga · January 13, 2025
Behind the Scenes of Qualcomm's Latest Options Trendsbenzinga.com
Via Benzinga · January 13, 2025
SpringWorks Therapeutics Stock Sees RS Rating Jump To 86investors.com
On Monday, SpringWorks Therapeutics stock hit a key technical milestone, seeing its Relative Strength Rating jump to 86.
Via Investor's Business Daily · January 13, 2025
Why Super Micro Computer Stock Is Sinking Todayfool.com
Via The Motley Fool · January 13, 2025
Gorilla Technology Stock Surges After Firm Boosts Buyback To $10M: Retail Turns Bullishstocktwits.com
Gorilla Technology maintained that its current share price fails to reflect its intrinsic value and long-term potential and is undervalued compared to other companies in the market.
Via Stocktwits · January 13, 2025
Scenes From The Last Employment Report Of Joe Biden’s Presidencytalkmarkets.com
Let’s focus on a couple of items from last Friday’s report beyond the headlines.
Via Talk Markets · January 13, 2025
How Trump's 'Maganomics' Could Power Industrials-Focused ETFsbenzinga.com
Maganomics is Trump's economic plan to boost domestic manufacturing, attracting investors and causing divided opinions. ETFs heavy in manufacturing may benefit.
Via Benzinga · January 13, 2025
Decoding CrowdStrike Holdings's Options Activity: What's the Big Picture?benzinga.com
Via Benzinga · January 13, 2025
Northrop Grumman's Options Frenzy: What You Need to Knowbenzinga.com
Via Benzinga · January 13, 2025
TD SYNNEX Stock Scores RS Rating Upgradeinvestors.com
On Monday, TD SYNNEX stock had its Relative Strength (RS) Rating upgraded to 86, up from 70 a day earlier.
Via Investor's Business Daily · January 13, 2025
Oil ETFs Jump At The Start Of 2025 As Supply Tightenscontent/com
Investors seeking to tap the oil rally could bet on the ETFs that are directly linked to the futures contracts.
Via Talk Markets · January 13, 2025
Aehr Test Systems Stock Dips Ahead of Q2 Earnings As Retail Watches For Signs Of Recoverystocktwits.com
Retail sentiment on Stocktwits is mixed as Aehr Test Systems’ stock declined pre-earnings, despite optimism around new semiconductor contracts.
Via Stocktwits · January 13, 2025
Artificial Intelligence (AI) Stocks Today: Why Nvidia, Micron, and TSMC Are Sinkingfool.com
Via The Motley Fool · January 13, 2025
The Unimaginable For Rates, Dollar, And Asset Valuestalkmarkets.com
Big trends are emerging for the stock market, interest rates, bond prices, housing and real estate mortgages.
Via Talk Markets · January 13, 2025
ON Semi Sees Utilization Cuts As EV Demand Softens, Analyst Warnsbenzinga.com
Bolton maintains Buy rating for ON Semiconductor and lowers price target to $66. Weak demand, inventory digestion, and lowered utilization rates expected to impact revenue and margins in near term.
Via Benzinga · January 13, 2025
What's Going On With Vera Therapeutics Stock?benzinga.com
Vera Therapeutics shares are trading lower by 4.7% Monday afternoon. The company announced an exclusive license agreement with Stanford University for VT-109.
Via Benzinga · January 13, 2025
Spotlight on GameStop: Analyzing the Surge in Options Activitybenzinga.com
Via Benzinga · January 13, 2025
Where BKV Stands With Analystsbenzinga.com
Via Benzinga · January 13, 2025
Stocks Edge Down Ahead Of Key Inflation Reports, Crude Hits 5-Month High, Bitcoin Sinks: What's Driving Markets Monday?benzinga.com
Traders adopted a cautious approach on Monday as they awaited two critical inflation reports due later this week, seeking clarity on Federal Reserve interest rate policy.
Via Benzinga · January 13, 2025
Why U.S. Steel Stock Soared Todayfool.com
Via The Motley Fool · January 13, 2025
BridgeBio, ARS Pharma, Harmony Bio Shine At JPM. But SpringWorks, Beam Take Their Lumps.investors.com
Some companies saw their shares skyrocket on preliminary reports, but others took hits.
Via Investor's Business Daily · January 13, 2025
DatChat (DATS) Stock Jumps After Last Week's Plunge: What's Going On?benzinga.com
DatChat shares climbed 14.5% on Monday. Monday's rally occurred despite no new company-specific updates.
Via Benzinga · January 13, 2025
Grains Report - Monday, Jan. 13content/com
Rice closed higher in continued speculative short covering and some new commercial buying.
Via Talk Markets · January 13, 2025
3 Energy Stocks to Buy After Biden's Offshore Oil Banbenzinga.com
Biden's drilling ban in certain US coastal areas may impact energy stocks in the future. Limited short-term effects, but could lead to higher prices.
Via Benzinga · January 13, 2025
Analyst Expectations For Halozyme Therapeutics's Futurebenzinga.com
Via Benzinga · January 13, 2025
Demystifying Magnolia Oil & Gas: Insights From 5 Analyst Reviewsbenzinga.com
Via Benzinga · January 13, 2025
Spirit AeroSystems’ Stock In Spotlight After $165M Sale Of Fiber Materials To Tex-Tech Industries: Retail’s Unconvincedstocktwits.com
Fiber Materials manufactures high-temperature materials and reinforced composites focusing on carbon and related composites. Its products are installed on critical defense platforms and NASA programs such as Stardust, Mars Curiosity, Orion, and Mars 2020.
Via Stocktwits · January 13, 2025
What's Going On With CVS, Humana and UnitedHealth Shares Monday?benzinga.com
Shares of health insurance companies are trading higher after The Centers for Medicare and Medicaid Services proposed a rise to Medicare Advantage payments.
Via Benzinga · January 13, 2025
Instacart, Uber Deal 'Makes More Sense Now,' Analyst Says: Here's Whybenzinga.com
Maplebear, which owns Instacart, could be an enticing acquisition for Uber as it looks to diversify revenue streams away from mobility.
Via Benzinga · January 13, 2025
Coterra Energy Stock Sees RS Rating Bumpinvestors.com
In a welcome move, Coterra Energy stock saw its Relative Strength Rating to 74 Monday, up from 65 a day earlier.
Via Investor's Business Daily · January 13, 2025
Sage Therapeutics Stock Eyes Best Day In 5 Years On Biogen’s Unsolicited Bid: Retail Piles Instocktwits.com
The two companies have collaborated since 2020 on the depression drug Zurzuvae, approved in 2023 by the FDA for treating postpartum depression.
Via Stocktwits · January 13, 2025
Market Whales and Their Recent Bets on LRCX Optionsbenzinga.com
Via Benzinga · January 13, 2025
Deep Dive Into Xylem Stock: Analyst Perspectives (6 Ratings)benzinga.com
Via Benzinga · January 13, 2025
Demystifying ARM Holdings: Insights From 10 Analyst Reviewsbenzinga.com
Via Benzinga · January 13, 2025
Pure Storage's Options: A Look at What the Big Money is Thinkingbenzinga.com
Via Benzinga · January 13, 2025
Will Banks Deliver? Earnings Report To Reveal True Picture Of U.S. Lending Sectortalkmarkets.com
U.S. banks face a key earnings season, testing the optimism that drove recent stock rallies.
Via Talk Markets · January 13, 2025
Gold Down Over 1%; Salarius Pharmaceuticals Shares Surgebenzinga.com
Via Benzinga · January 13, 2025
TikTok Ban Deadline Ahead: What Will Happen To App On Your Phone?benzinga.com
A TikTok ban could be bad for content creators and good for social media rivals. A look at what's next, including what happens to the app on your phone.
Via Benzinga · January 13, 2025
Biogen Bid For Sage Therapeutics Could Strengthen Neurology Strategy: Analystsbenzinga.com
Biogen proposes acquiring Sage Therapeutics for $7.22 per share, as analysts highlight the strategic value of Zurzuvae's success in postpartum depression.
Via Benzinga · January 13, 2025
Why Shares of Quantum Computing Stocks D-Wave Quantum, Quantum Computing, and Rigetti Computing Were Plunging Again Todayfool.com
Via The Motley Fool · January 13, 2025
The Analyst Verdict: Blackstone In The Eyes Of 19 Expertsbenzinga.com
Via Benzinga · January 13, 2025
These stocks have an unusual volume in today's sessionchartmill.com
Discover the stocks with unexpected trading volume in today's session on the US markets.
Via Chartmill · January 13, 2025
Citi Q4 Earnings Preview: Analysts Upbeat On Future Prospects, Retail Remains Neutralstocktwits.com
Analysts expect Citi to post fourth-quarter earnings per share of $1.22 on revenue of $19.51 billion.
Via Stocktwits · January 13, 2025
Bitcoin's Big Macro Data Week: Here's What To Watchbenzinga.com
Bitcoin (CRYPTO: BTC) faces several key macroeconomic data releases this week, causing heightened volatility in the markets.
Via Benzinga · January 13, 2025